This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing Biohaven's baseline data for Troriluzole in patients with Spinocerebellar Ataxia (SCA)
Ticker(s): BHVNWho's the expert?
Institution: Mount Sinai
- Board certified Neurologist and movement disorders specialist
- Treats 22 patients with Spinocerebellar Ataxia
- Very familiar with the use of Troriluzole and can discuss in depth
Interview GoalThis conversation will focus on the treatment landscape and potential use Troriluzole in patients with SCA.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
